of preserving beta cell function to maintain glycemic control in patients with type 2 diabetes, the predictive value of baseline beta cell function for future glycemic control in patients with type 2 diabetes remains unclear. Serum and urinary C-peptide immunoreactivity (CPR) are markers of beta cell function widely used in clinical settings [6, 7] . Since CPR is not extracted by the liver, it reflects endogenous insulin secretion more accurately than does insulin. Therefore, in this study we conducted a retrospective chart review to examine the relationship between baseline CPR values and future glycemic control in patients with type 2 diabetes.
(NGSP) value according to the JDS statement [12] .
Baseline plasma glucose and serum CPR levels were measured after overnight fasting and 2 h after breakfast during admission, within a few days after admission under basal-bolus insulin therapy using regular and NPH insulin. Insulin therapy was started at a dose of 0.2 -0.3 U/kg, and then titrated to achieve good glycemic control (FPG <130 mg/dL and postprandial plasma
subjects, Materials and Methods
Initially, we conducted a chart review of 896 patients with type 2 diabetes who were admitted to our hospital between 2000 and 2007, as described elsewhere [8, 9] . Most patients had been admitted to our hospital because of poor glycemic control, and initially received basal-bolus insulin therapy during admission, usually for 1 -2 weeks. We excluded 3 subjects positive for glutamic acid decarboxylase (GAD) or insulinoma-associated antigen-2 (IA-2) antibody. We also excluded 41 subjects with renal failure defined as serum creatinine level ≥ 2 mg/dL, as renal insufficiency affects CPR level. Beta cell function may be transiently impaired by marked hyperglycemia, so-called glucose toxicity. It has been reported that the beta cell response to glucose is blunted above a plasma glucose level of 180 mg/dL [10] . Therefore, 163 subjects with fasting plasma glucose (FPG) level ≥200 mg/dL on the day of CPR measurement were also excluded, and 689 subjects were judged to be eligible for this analysis. Out of the 689 subjects, 513 (74.5%) who were able to be followed up for 2 years were analyzed in this study (321 men and 192 women, age 63 ± 12 years (mean ± SD), duration of diabetes 12.5 ± 9.6 years, BMI 24.4 ± 4.1 kg/m 2 , Table 1 ). There was no significant difference in clinical characteristics between the patients included in this study and those excluded from this study because the follow-up period was <2 years (N = 176, data not shown). The patients were treated according to the Japan Diabetes Society (JDS) guidelines for treatment of diabetes [11] . Before admission, 50.3% of subjects were treated with a sulfonylurea (SU), 1.8% with a glinide, 15.0% with a biguanide (BG), 8.4% with a thiazolidinedione (TZD), 28.9% with an α-glucosidase inhibitor (α-GI) and 17.0% with insulin (Table 1) , and 29.0% were receiving no medication.
This study was conducted according to the principles expressed in the Declaration of Helsinki and was approved by the ethical review committee of Keio University School of Medicine, Tokyo, Japan.
Measurements
All measurements except CPR measurements were performed on admission by the Department of Laboratory Medicine, Keio University School of Medicine with routine automated laboratory methods. HbA1c was measured by HPLC and expressed as the National Glycohemoglobin Standardization Program (two-sided). All statistical analyses were conducted using the Statistical Package for the Social Sciences (version 19.0; SPSS, Chicago, IL, USA).
Results

Comparison of baseline characteristics according to glycemic control after 2 years
At discharge, 18.9% of the subjects were being treated with a SU, 6.2% with a glinide, 12.5% with a BG, 0.6% with a TZD, 34.6% with an α-GI and 67.1% with insulin, and only 3.5% were receiving no medication ( Table 1) .
Mean HbA1c level was 9.9 ± 1.8% on admission and improved to 7.6 ± 1.4% after 2 years (P <0.001 by paired t-test). Comparison of baseline characteristics according to glycemic control at 2 years after admission is shown in Table 2 . One-third (32.5%) of the subjects had good glycemic control after 2 years (i.e., HbA1c <6.9%).
Serum and urinary CPR indices were higher in those with good glycemic control (all P <0.05). The proportion of male subjects, duration of diabetes, family history of diabetes, and BMI were also significantly different between the groups (all P <0.05). Fewer subjects used medication before admission in those with good control, while there was no significant difference in the proportion of subjects using medication at discharge between the groups. There was no significant difference in frequency of micro-and macrovascular complications between the groups (all P >0.1, data not shown).
Associations between CPR indices and glycemic control
Univariate logistic regression analysis was performed to know the relation of variables shown in Table 2 to the good or inadequate glycemia 2 years later. Results for 6 CPR-related variables were shown in Table 3 : none of other variables listed in Table 2 was significantly related to the glycemic outcome 2 years later by the logistic regression analysis. Higher fasting and postprandial CPR indices, and urinary CPR index were significantly related to good glycemic control after 2 years (all P <0.05, Table 3 ). When the variables were standardized by SD to compare the odds ratios, postprandial CPR index showed the highest odds ratio (OR) among the indices (OR 1.40 for 1 SD increase, 95% confidence interval (CI) 1.15-1.70, P = 0.001, Table 3 ). There was a significant negative correlation between postprandial CPR index and HbA1c after 2 glucose <180 mg/dL) without hypoglycemia according to the guidelines of the JDS [11] . During basal-bolus insulin therapy, insulin secretagogues (SU and glinides) were discontinued, but insulin non-secretagogues (BG, TZD and α-GI) were usually continued. All patients were receiving the ideal dietary calorie intake calculated from their ideal body weight (i.e., height (m) 2 x 22 x 25 kcal/kg; carbohydrate 50-60%, protein 15-20% and fat 20-25% based on a meal-exchange plan) at the times of collection of blood samples. Plasma glucose was measured by glucose oxidase method, and CPR was measured by EIA. Coefficient of variation (CV) of the within-run and between-day precision of CPR was 2.39% and 2.97%, respectively. Fasting and postprandial CPR indices were calculated as follows: fasting or postprandial serum CPR (ng/mL) / fasting or postprandial plasma glucose (mg/dL) x 100, respectively. In addition, 24 h urinary CPR was also measured. Urinary CPR index was calculated as 24 h urinary CPR (µg/day) / FPG (mg/dL).
Estimated glomerular filtration rate (eGFR: mL/ min/1.73 m 2 ) was calculated according to the Statement of the Japan Nephrology Society (JNS) as follows: 194 x serum creatinine (mg/dL) -1.094 x age (years) -0.287 (x 0.739 for women) [13] .
Diabetic complications were evaluated in detail during admission. Diagnosis of diabetic retinopathy was performed by ophthalmologists.
Statistical analysis
Descriptive statistics were calculated for the baseline characteristics. Glycemic control was classified into two groups according to the JDS guidelines as follows: good; HbA1c <6.9% and inadequate; HbA1c ≥6.9% [11] . Homogeneity of the distributions of the baseline factors between the groups was examined with unpaired t-test or Fisher's exact test. The association between CPR levels and glycemic control after 2 years was evaluated with a logistic regression model for each CPR parameter. The CPR parameters were standardized (SD = 1, mean = 0) in the analysis to compare the effect on HbA1c after two years among these parameters. Multivariate logistic regression analysis was used to evaluate the effect of postprandial CPR index on glycemic control after 2 years adjusted for other confounders. The association between postprandial CPR index and HbA1c after 2 years was also estimated with Pearson's correlation coefficient. All data are expressed as mean ± SD, and significance levels for all tests were α = 0.05 in those trials. Although several studies have examined the correlation between CPR level and treatment outcome [14, 15] , the correlation remains to be established and there are few available data, especially in the Japanese population. The present study showed an association between baseline CPR and future glycemic control in the Japanese population, using our cohort with a relatively large sample size and long duration of follow-up. Although this study had a retrospective design, our results reflect the "real world" situation.
In this study, we used CPR to plasma glucose ratio i.e., CPR index, as a marker of beta cell function. It is of note that when CPR and plasma glucose levels were separately included in the multivariate logistic regression model, the association between CPR itself and future glycemic control remained significant (data not shown). Since an advantage of CPR measurement is that it reflects endogenous insulin secretary capacity even under insulin treatment, CPR measurement can be used widely in clinical settings.
In this study, we further compared the predictive value among CPR indices. As a result, postprandial CPR index showed the greatest odds for predicting future good glycemic control compared with fasting CPR index or urinary CPR index, while 95%CI of OR for CPR indices mostly overlapped each other. This result is consistent with our previous finding that postprandial CPR index showed the greatest odds for predicting future insulin therapy compared with other CPR indices [8, 16] . The reason for this may be that CPR in a postprandial state more closely reflects the maximal functional capacity of beta cells compared with a years (r = -0.156, P <0.001). Postprandial CPR index was significantly related to good glycemic control after 2 years in both the subgroup of patients in whom insulin therapy had been introduced at discharge (OR 1.26 for 1 unit increase, 95%CI 1.01-1.57, P = 0.038) and the subgroup in whom it had not (OR 1.32, 95%CI 1.05-1.66, P = 0.019). Furthermore, the association between postprandial CPR index and good glycemic control after 2 years remained significant after adjustment for other covariates including medication which related to good glycemic control in Table 2 (OR 1.23 for 1 unit increase, 95%CI 1.03-1.48, P = 0.021, Table  4 ). However, receiver-operating characteristic (ROC) analysis of postprandial CPR index for predicting good glycemic control revealed a significant but small area under the curve (AUC) (0.597, 95%CI 0.542-0.651, P <0.001, cut-off value: 1.99 with 47.9% sensitivity and 69.4% specificity).
discussion
In this study, we showed that postprandial CPR index was associated with future glycemic control in patients with type 2 diabetes. Logistic regression analysis estimated that a 1 unit increase in postprandial CPR index was associated with an ~30% increase in the odds of achieving good glycemic control after 2 years. The association between deterioration of beta cell function and worsening of glycemic control has been shown in prospective studies such as UKPDS and ADOPT [2, 5] . However, a correlation between baseline beta cell function and future glycemic control was not reported = 0.015), suggesting that the effect of previous medication on the CPR value was relatively small. On the other hand, although we carefully adjusted for the effects of medication on future glycemic control in the current study, the dose and duration of medication before admission were not available. Thus, these factors might affect future glycemic control. Also, we did not consider changes in medication after discharge in this study; however, more than 95% of the patients had started medication and most patients had already initiated insulin therapy at discharge. At 2 years after the discharge, proportion of the patients treated with insulin was significantly higher in the inadequate glycemic control group compared with the good glycemic control group (70.2% vs. 46.7%, P <0.001). In our previous report using the same cohort, we also have noted that insulin users at the final visit rather showed poorer glycemic control compared with non-insulin users [8] , indicating that poor glycemic control in our study was not only due to insufficient intensification of the therapy. Finally, the patients in this study showed poor glycemic control and had been hospitalized and treated with basal-bolus insulin therapy during admission. Therefore, it may not be possible to generalize the results of this study to outpatients with good to moderate glycemic control, and future studies are needed to answer this question. The strengths of this study include 1) the use of a cohort with detailed clinical information including medication, 2) the large sample size and long follow-up duration, 3) that the study was conducted in a single institution, and 4) that all the physicians were specialists in diabetes and treated the patients according to the JDS guidelines for treatment of diabetes.
In conclusion, higher beta cell function assessed by CPR indices was associated with better glycemic control thereafter, confirming the importance of beta cell function for maintaining adequate glycemic control in patients with type 2 diabetes. Postprandial CPR index may add predictive utility to other predictors of future glycemic control and help in the selection of optimal treatment for individual patients with type 2 diabetes. To maintain adequate glycemic control in patients with type 2 diabetes, new therapeutic strategies aiming to foster the recovery of beta cell function are warranted.
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The authors have no conflict of interest. The authors thank Dr. Wendy Gray for editing the manuscript. fasting state, due to the presence of factors stimulating insulin secretion such as postprandial glucose excursion and incretin.
The association between postprandial CPR index and future glycemic control remained significant after adjustment for other confounders including the use of insulin. Insulin is the most potent therapy to improve glycemic control [17] , and improvement of beta cell function after introducing insulin therapy has been reported [18, 19, 20] . However, in UKPDS, deterioration of glycemic control was similarly observed among patients treated with an SU, BG or insulin [2, 3] . Consistent with this, the association between baseline CPR value and future glycemic control observed in this study does not seem to be flawed by anti-diabetic medication, which was confirmed in multivariate logistic regression analysis. A negative correlation between postprandial C-peptide and plasma glucose levels has been reported [21, 22] , which may result in poor glycemic control in subjects with a low CPR index. Incretin-based therapy has been shown to improve beta cell function [23] ; however, it was not available in Japan during this study period.
Multivariate logistic regression analysis showed that, in addition to postprandial CPR index, male sex, shorter duration of diabetes, absence of family history of diabetes, lower BMI, lower HbA1c, administration of a lower number of oral hypoglycemic agents (OHA) and no insulin use before admission were significantly related to good glycemic control, which is largely in line with the results of previous studies [14, 15] . Accordingly, these results indicate that the predictive value of postprandial CPR index is relatively small. Indeed, ROC analysis of postprandial CPR index for predicting good glycemic control revealed a significant but small AUC. Although in this study we were not able to assess insulin sensitivity, it would be interesting to determine whether CPR index adjusted by insulin sensitivity (i.e., disposition index) improves the predictive value for future glycemic control.
There are limitations of this study. Since our study had a retrospective design, unknown confounders might exist. Medication including insulin at the time of CPR measurements might affect CPR levels, but this should affect both groups. Since the wash-out period for previous medication was short in this study, the use of SU, which stimulates insulin secretion, before admission might affect CPR levels. However, the postprandial CPR level was rather lower in SU users than in non-SU users (4.04 ± 2.17 vs. 4.58 ± 2.80 ng/mL, P
